These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1183 related articles for article (PubMed ID: 28843021)

  • 1. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
    Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
    Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The gut microbiome in Parkinson's disease].
    Bedarf JR; Hildebrand F; Goeser F; Bork P; Wüllner U
    Nervenarzt; 2019 Feb; 90(2):160-166. PubMed ID: 30171304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease.
    Yang ZJ; Wei J; Mao CJ; Zhang JR; Chen J; Ji XY; Liu JY; Shen Y; Xiong KP; Huang JY; Yang YP; Liu CF
    Sleep Breath; 2016 Dec; 20(4):1285-1292. PubMed ID: 27259748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metagenomic Analysis Reveals Large-Scale Disruptions of the Gut Microbiome in Parkinson's Disease.
    Metcalfe-Roach A; Cirstea MS; Yu AC; Ramay HR; Coker O; Boroomand S; Kharazyan F; Martino D; Sycuro LK; Appel-Cresswell S; Finlay BB
    Mov Disord; 2024 Oct; 39(10):1740-1751. PubMed ID: 39192744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease.
    Heinzel S; Aho VTE; Suenkel U; von Thaler AK; Schulte C; Deuschle C; Paulin L; Hantunen S; Brockmann K; Eschweiler GW; Maetzler W; Berg D; Auvinen P; Scheperjans F
    Ann Neurol; 2020 Aug; 88(2):320-331. PubMed ID: 32441370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease.
    Postuma RB; Gagnon JF; Vendette M; Montplaisir JY
    Brain; 2009 Dec; 132(Pt 12):3298-307. PubMed ID: 19843648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships Between Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease: Indication from Gut Microbiota Alterations.
    Zhang P; Huang P; Li Y; Du J; Luo N; He Y; Liu J; He G; Cui S; Zhang W; Li G; Shen X; Jun L; Chen S
    Aging Dis; 2024 Feb; 15(1):357-368. PubMed ID: 37307829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T-cell Transcription Factors in Idiopathic REM Sleep Behavior Disorder and Parkinson's Disease.
    De Francesco E; Terzaghi M; Storelli E; Magistrelli L; Comi C; Legnaro M; Mauri M; Marino F; Versino M; Cosentino M
    Mov Disord; 2021 Jan; 36(1):225-229. PubMed ID: 32649001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism.
    Al-Qassabi A; Tsao TS; Racolta A; Kremer T; Cañamero M; Belousov A; Santana MA; Beck RC; Zhang H; Meridew J; Pugh J; Lian F; Robida MD; Ritter M; Czech C; Beach TG; Pestic-Dragovich L; Taylor KI; Zago W; Tang L; Dziadek S; Postuma RB
    Mov Disord; 2021 Apr; 36(4):895-904. PubMed ID: 33232556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism.
    Barichella M; Severgnini M; Cilia R; Cassani E; Bolliri C; Caronni S; Ferri V; Cancello R; Ceccarani C; Faierman S; Pinelli G; De Bellis G; Zecca L; Cereda E; Consolandi C; Pezzoli G
    Mov Disord; 2019 Mar; 34(3):396-405. PubMed ID: 30576008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study.
    Knudsen K; Fedorova TD; Hansen AK; Sommerauer M; Otto M; Svendsen KB; Nahimi A; Stokholm MG; Pavese N; Beier CP; Brooks DJ; Borghammer P
    Lancet Neurol; 2018 Jul; 17(7):618-628. PubMed ID: 29866443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells.
    Smith AM; Depp C; Ryan BJ; Johnston GI; Alegre-Abarrategui J; Evetts S; Rolinski M; Baig F; Ruffmann C; Simon AK; Hu MTM; Wade-Martins R
    Mov Disord; 2018 Oct; 33(10):1580-1590. PubMed ID: 30294923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tract-Based Spatial Statistics Reveal Lower White Matter Integrity Specific to Idiopathic Rapid Eye Movement Sleep Behavior Disorder as a Proxy for Prodromal Parkinson's Disease.
    Ohlhauser L; Smart CM; Gawryluk JR
    J Parkinsons Dis; 2019; 9(4):723-731. PubMed ID: 31498130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson's Disease (PD).
    Du J; Zhang P; Tan Y; Gao C; Liu J; Huang M; Li H; Shen X; Huang P; Chen S
    Mov Disord; 2024 Aug; 39(8):1397-1402. PubMed ID: 38561921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.
    Concha-Marambio L; Weber S; Farris CM; Dakna M; Lang E; Wicke T; Ma Y; Starke M; Ebentheuer J; Sixel-Döring F; Muntean ML; Schade S; Trenkwalder C; Soto C; Mollenhauer B
    Mov Disord; 2023 Apr; 38(4):567-578. PubMed ID: 36781413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
    Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
    Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodromal Marker Progression in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: Sample Size for Clinical Trials.
    Alotaibi F; Pelletier A; Gagnon JF; Montplaisir JY; Postuma RB
    Mov Disord; 2019 Dec; 34(12):1914-1919. PubMed ID: 31571268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.
    Fereshtehnejad SM; Montplaisir JY; Pelletier A; Gagnon JF; Berg D; Postuma RB
    Mov Disord; 2017 Jun; 32(6):865-873. PubMed ID: 28429825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: A harbinger of freezing of gait?
    Alibiglou L; Videnovic A; Planetta PJ; Vaillancourt DE; MacKinnon CD
    Mov Disord; 2016 Nov; 31(11):1711-1719. PubMed ID: 27250871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-Year Follow-up of [
    Kogan RV; Janzen A; Meles SK; Sittig E; Renken RJ; Gurvits V; Mayer G; Leenders KL; Oertel WH;
    Mov Disord; 2021 Jan; 36(1):230-235. PubMed ID: 32909650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.